34 Facts About Oscar Kashala

Dr Oscar Kashala Lukumuena was born on August 4,1954 and is a Boston-based scientist, clinical researcher, university professor, and senior executive in the biopharmaceutical industry in the United States of America.

Oscar Kashala is a politician in the Democratic Republic of the Congo and was a reformer candidate in the 2006 presidential election and 2011 presidential elections.

Oscar Kashala graduated from Kinshasa University Medical School in 1980 with honors.

Oscar Kashala previously took a leave of absence from his employers to campaign in the 2006 elections after years of residence in the United States.

Oscar Kashala ran for the Office of the President of DRC for the Presidential elections on November 28,2011.

Oscar Kashala received security services from AQMI Strategy Corporation of Orlando, Florida, before the elections.

Oscar Kashala obtained a Cancer Biology and Retrovirology Fellowship in Boston at Harvard University.

Oscar Kashala received a Doctor of Science degree from Harvard University in 1992.

Oscar Kashala held senior executive positions in the pharmaceutical industry and senior advisory positions to the various head of state in Africa.

Oscar Kashala has worked with governments both in Central and West Africa, South East Asia, and South America in matters related to public health, global security, education, foreign assistance, and international finance in countries, including Angola, the Democratic Republic of Congo, Egypt, Gabon, Guinea Bissau, Republic of Guinea, Senegal, The Gambia, Uganda, Thailand, Colombia, and the Philippines.

Oscar Kashala consulted on trade and commerce with firms in the private sector, government and non-government organizations, and the United States Congress, European Union, and China.

In May 2004, Oscar Kashala was invited by the Government of DRC to participate in discussion about country's development programs.

In 2005, Oscar Kashala created a political party, Union for the Rebuilding of Congo, and registered it with the government on September 21,2005.

Oscar Kashala has assembled a team of 13 campaign advisers, who have helped him raise $52,000 in the US and Europe.

Oscar Kashala spent about $100,000 of his own money to finance a presidential campaign in 2006.

Oscar Kashala's campaign was meddled with by the Government that used tactics such as house arrests, arrest of his legal team members, imprisonment and torture of several UREC members, and illegal grounding of his planes.

Oscar Kashala was viewed as the game changer in Congolese politics.

Oscar Kashala instructed his teams to stop campaigning for the scheduled elections and to launch their plan for pacification of DRC due to widesprean violence and national instability across the DRC.

Oscar Kashala was the only candidate from the Congolese political opposition to have been invited by President Joseph Kabila to attend his swearing-in ceremony.

Oscar Kashala is the chairman of the Board of Global Enterprise Services Corporation, a holdings company with many global dealings, mainly for-profit ventures.

Oscar Kashala is the President of the Harold Michael Kashala Foundation for Health Care and Partnership, Inc.

Oscar Kashala was born on August 4,1954, in Lubumbashi, Haut-Katanga District, from Congolese parents.

Son of a retired military sergeant in the Force Publique, the Congolese Army under Belgian colonization, Oscar Kashala was raised in an environment that focused on strict discipline, Christian faith, hard work, excellence in education and family values.

Oscar Kashala excelled as a student and as a boy scout.

Oscar Kashala graduated from Kinshasa University Medical School in 1980 with honors, and trained in internal medicine and pathology at the University of Kinshasa, then at the University of Lausanne and University of Geneva Medical Schools.

Oscar Kashala received a Doctor of Science degree from Harvard University in 1992.

Oscar Kashala began his career at Cambridge Biotech Corporation as a Director of Medical Affairs and Tropical Diseases and Director of Molecular Pathogenesis Laboratory.

Oscar Kashala initiated the first laboratory HIV-1 vaccine development studies ever conducted based on the use of virus strains that are common in Africa, with the support of the US Government, the World Health Organization, and other partners in the industry.

Oscar Kashala later joined EMD Serono, Inc, an Affiliate of Merck KGaA.

Oscar Kashala was appointed Senior Director of Clinical Oncology Development and Head, Oncology Development, with overall responsibility for the clinical research and development activities in the US.

In March 2013, Oscar Kashala was appointed Senior Vice President for Research and Development and Senior Vice President for Business Development, Africa Goal Strategy for Nanobiosym, Inc.

In 2015, Oscar Kashala joined Affimed, Inc as vice-president, Medical, US.

Oscar Kashala has been very active in the area of humanitarian aid and philanthropy.

Oscar Kashala's efforts were instrumental in securing an amendment to the Iraq Supplemental Appropriations bill to provide $13.2 million in critical funding for DRC.